Moreover, the underlying mechanism of aloperine showing ideal antitumor activity in IDH wild-type ICC cells should be addressed, as it could guide the obtainment of aloperine derivatives that better target IDH-mutant tumors. Here, IDH2 is linked to intrahepatic cholangiocarcinoma.